Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone–-releasing hormone effect). Distinction from poor tumor differentiation-Reference-Cited by-同舟云学术

Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone–-releasing hormone effect). Distinction from poor tumor differentiation

Published:1994-03-01 Issue:5 Volume:73 Page:1472-1477
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Smith David M.,Murphy William M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference18 articles.

1. Estrogen-treated prostatic cancer.The variation in responsiveness of tumor cells

2. Series 2;Mostofi,1973

3. . Diseases of the prostate gland and seminal vesicles. In: editor. Urological pathology. Philadelphia: WB Saunders, 1989: 179–84.

4. A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma

5. Comparison of leuprolide and diethylstilbestrol for stage D2 adenocarcinoma of prostate

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reprint of: morphologic spectrum of treatment-related changes in prostate tissue and prostate cancer: an updated review;Human Pathology;2023-03

2. Morphologic spectrum of treatment-related changes in prostate tissue and prostate cancer: an updated review;Human Pathology;2022-09

3. Prostate Cancer in Male-to-Female Transgender Individuals;American Journal of Surgical Pathology;2022-08-26

4. Nondetectable Prostate Carcinoma (pT0) after Radical Prostatectomy: A Narrative Review;Current Oncology;2022-02-23

5. Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells;BMC Veterinary Research;2020-09-24